Patient Advocates Applaud Cancer Drug Parity Act filed in both the U.S. House and Senate

“We are thrilled that this bi-partisan group of leaders in both the House and Senate have come together to help cancer patients ensure that they have affordable access to all available treatments,” said Robin Levy, Senior Director of Public Policy and Advocacy for the International Myeloma Foundation who chairs the Coalition to Improve Access to Cancer Care.  “When passed into law, the Cancer Drug Parity Act will ensure that cancer patients—who are in the fight of their lives—don’t have to fight for the medications their oncologist prescribes.”

This legislation ensures that any health plan covering cancer care offer patients the same level of cost-sharing for all forms of cancer medicine.

Read full piece here